Twist Bioscience Reports Q2 2026 Earnings in Transcript Release
Twist Bioscience released its second‑quarter 2026 financial results and posted the full earnings call transcript. The company highlighted revenue growth and updates to its DNA‑synthesis platform. The transcript is available through Benzinga's API.
Advertisement: Article Inline